Condition

Anaplastic Large Cell Lymphoma clinical trials and research

• 7Clinical trials
• 3Countries

Newest Anaplastic Large Cell Lymphoma clinical trials

All recruiting trials (7)

• Non-Hodgkin Lymphoma Sample Collection for MRD Testing

  This study tests a blood-based and tissue-based approach to see if a molecular residual disease test can detect lingering cancer in adults with aggressive NHL who are starting standard therapy.

  Recruiting Natera, Inc. · Austin, Texas · NCT07750886

• Azacitidine and abatacept for relapsed or refractory T-cell lymphoma

  This study tests a combination of azacitidine and abatacept to see if it can shrink tumors in adults whose T-cell lymphoma has come back or not responded to treatment.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07388563

• Alectinib plus duvelisib for ALK-positive anaplastic large cell lymphoma

  This trial tests whether combining alectinib with duvelisib is a safe, time-limited treatment for people with relapsed or refractory ALK-positive anaplastic large cell lymphoma.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07001384

• Using a modified virus to treat patients with T-cell lymphoma

  This study is testing a modified virus combined with immunotherapy to see if it can safely treat patients with different types of T-cell lymphoma.

  Recruiting at 2 sites Phase 1 Mayo Clinic · Scottsdale, Arizona and 1 other locations · NCT06508463

• Treatment for relapsed Hodgkin's and Anaplastic Large Cell Lymphoma using LCAR-HL30

  This study is testing a new treatment called LCAR-HL30 to see if it can help adults with relapsed Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma feel better.

  Recruiting Phase 1 Ruijin Hospital · Shanghai · NCT06494371

• Alectinib treatment for ALK-positive cancers in adults and children

  This study is testing if alectinib, a drug for lung cancer, can help treat different types of ALK-positive cancers in both adults and children.

  Recruiting at 24 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05770037

• Donor stem cell transplant with chemotherapy and radiation for blood cancers

  This study is testing if a donor stem cell transplant combined with different doses of chemotherapy and radiation can help people with blood cancers recover better.

  Recruiting Phase 2 Fred Hutchinson Cancer Center · Seattle, Washington · NCT04195633

Related topics

Quick answers

How many Anaplastic Large Cell Lymphoma clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (5 trials), United Kingdom (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 4, Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →